Literature DB >> 19839641

Scientific and regulatory perspectives on metabolizing enzyme-transporter interplay and its role in drug interactions: challenges in predicting drug interactions.

Lei Zhang1, Yuanchao Zhang, Shiew-Mei Huang.   

Abstract

Both metabolizing enzymes and drug transporters play important roles in modulating drug absorption, distribution, metabolism and elimination. Acting alone or in concert with each other they can affect the pharmacokinetics and pharmacodynamics of a drug. This paper will present cases from recent reviews of new drug application (NDA) and literature that exemplify the role of metabolizing enzyme-transporter interplay in a drug's disposition, and discuss challenges in predicting drug interactions. Finally, the discussion will focus on the need to leverage current knowledge to obtain more meaningful drug interaction information.

Mesh:

Substances:

Year:  2009        PMID: 19839641     DOI: 10.1021/mp900132e

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  21 in total

Review 1.  Drug interactions with herbal medicines.

Authors:  Shaojun Shi; Ulrich Klotz
Journal:  Clin Pharmacokinet       Date:  2012-02-01       Impact factor: 6.447

2.  Sensitivity of intravenous and oral alfentanil and pupillary miosis as minimal and noninvasive probes for hepatic and first-pass CYP3A induction.

Authors:  E D Kharasch; A Francis; A London; K Frey; T Kim; J Blood
Journal:  Clin Pharmacol Ther       Date:  2011-05-11       Impact factor: 6.875

Review 3.  Interplay of drug metabolizing enzymes with cellular transporters.

Authors:  Michaela Böhmdorfer; Alexandra Maier-Salamon; Juliane Riha; Stefan Brenner; Martina Höferl; Walter Jäger
Journal:  Wien Med Wochenschr       Date:  2014-09-10

Review 4.  Use of in vivo animal models to assess pharmacokinetic drug-drug interactions.

Authors:  Cuyue Tang; Thomayant Prueksaritanont
Journal:  Pharm Res       Date:  2010-04-29       Impact factor: 4.200

5.  Transporters in Regulatory Science: Notable Contributions from Dr. Giacomini in the Past Two Decades.

Authors:  Lei Zhang; Qi Liu; Shiew-Mei Huang; Robert Lionberger
Journal:  Drug Metab Dispos       Date:  2022-06-29       Impact factor: 3.579

Review 6.  Intracellular drug concentrations and transporters: measurement, modeling, and implications for the liver.

Authors:  X Chu; K Korzekwa; R Elsby; K Fenner; A Galetin; Y Lai; P Matsson; A Moss; S Nagar; G R Rosania; J P F Bai; J W Polli; Y Sugiyama; K L R Brouwer
Journal:  Clin Pharmacol Ther       Date:  2013-04-10       Impact factor: 6.875

Review 7.  Transporters as Drug Targets in Neurological Diseases.

Authors:  H Qosa; L A Mohamed; S Alqahtani; B S Abuasal; R A Hill; A Kaddoumi
Journal:  Clin Pharmacol Ther       Date:  2016-08-27       Impact factor: 6.875

8.  The effect of ketoconazole on the pharmacokinetics and pharmacodynamics of inhaled fluticasone furoate and vilanterol trifenatate in healthy subjects.

Authors:  Rodger Kempsford; Ann Allen; Joanne Bal; David Rubin; Lee Tombs
Journal:  Br J Clin Pharmacol       Date:  2013-06       Impact factor: 4.335

9.  Tacrine sinusoidal uptake and biliary excretion in sandwich-cultured primary rat hepatocytes.

Authors:  Loqman A Mohamed; Amal Kaddoumi
Journal:  J Pharm Pharm Sci       Date:  2014       Impact factor: 2.327

10.  Inhibition of P-glycoprotein Gene Expression and Function Enhances Triptolide-induced Hepatotoxicity in Mice.

Authors:  Ling-Lei Kong; Xiao-Mei Zhuang; Hai-Ying Yang; Mei Yuan; Liang Xu; Hua Li
Journal:  Sci Rep       Date:  2015-07-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.